Should We Test for Diastolic Dysfunction? How and How Often?

Sheldon E Litwin1, Michael R Zile1

  • 1Department of Internal Medicine, Division of Cardiology, Medical University of South Carolina and the Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina.

Insights

Diagnosing heart failure (HF) involves assessing ventricular filling pressures. Direct measurement using implanted sensors is the only diastolic assessment proven to reduce HF hospitalizations.

Area of Science:

  • Cardiology
  • Medical Diagnostics
  • Heart Failure Research

Background:

  • Heart failure (HF) symptoms largely stem from elevated left and/or right ventricular filling pressures.
  • Abnormal diastolic function, though difficult to define, contributes significantly to these elevated pressures.
  • Diastolic dysfunction assessment aids in HF diagnosis, prognosis, and treatment guidance.

Purpose of the Study:

  • To evaluate diagnostic and prognostic tools for heart failure related to diastolic dysfunction.
  • To assess the efficacy of various methods in measuring or inferring ventricular filling pressures.
  • To identify methods that can guide heart failure therapy and improve outcomes.

Main Methods:

  • Review of existing evidence on echocardiographic parameters and serum natriuretic peptide levels.
  • Analysis of the utility of inferior vena cava measurements in acute decompensated HF.
  • Evaluation of direct left ventricular (LV) filling pressure measurements via implanted sensors.

Main Results:

  • Individual echocardiographic parameters show weak correlation with direct LV filling pressures; combined parameters improve accuracy.
  • Elevated serum natriuretic peptide levels are a key HF diagnostic criterion but lack evidence for guiding therapy.
  • Direct LV filling pressure measurement via implanted sensors is the only "diastolic assessment" proven to reduce HF hospitalizations.

Conclusions:

  • Current non-invasive methods have limitations in accurately guiding HF therapy.
  • Further research is needed for serial echocardiography and natriuretic peptide monitoring.
  • Implanted pressure sensors offer a proven method for reducing HF hospitalizations through direct diastolic pressure assessment.